Qualicorp Consultoria e Corretora de Seguros S.A. (BVMF:QUAL3)
Brazil · Delayed Price · Currency is BRL | Market Cap | 532.27M -15.2% |
| Revenue (ttm) | 1.43B -7.5% |
| Net Income | 10.67M +62.1% |
| EPS | 0.04 +61.7% |
| Shares Out | 283.12M |
| PE Ratio | 49.91 |
| Forward PE | 4.49 |
| Dividend | 0.01 (0.30%) |
| Ex-Dividend Date | Jun 30, 2026 |
| Volume | 1,083,700 |
| Average Volume | 4,061,255 |
| Open | 1.870 |
| Previous Close | 1.880 |
| Day's Range | 1.840 - 1.900 |
| 52-Week Range | 1.580 - 2.820 |
| Beta | 0.51 |
| RSI | 47.87 |
| Earnings Date | May 13, 2026 |
About BVMF:QUAL3
Qualicorp Consultoria e Corretora de Seguros S.A. operates as a multi-solution company in Brazil. The company provides private healthcare plans, markets and manages other insurance or complementary services, and provides services for the capture, routing, authorization, and billing of medical and hospital services. It also offers medical auditing services, medical billing processing, call center, licensing of hospital network and claims management systems, and other outsourced support services. In addition, the company provides mass insurance b... [Read more]
Financial Performance
In 2025, BVMF:QUAL3's revenue was 1.43 billion, a decrease of -7.46% compared to the previous year's 1.54 billion. Earnings were 10.67 million, an increase of 62.11%.
Financial StatementsNews
Qualicorp Consultoria e Corretora de Seguros Earnings Call Transcript: Q4 2025
Strong cash generation and improved margins marked Q4 2025, with adjusted EBITDA margin rising to 41.9% and net debt down 12% year-over-year. Portfolio retention and product exclusivities improved, while sector consolidation and operator instability required agile portfolio management.
Qualicorp Consultoria e Corretora de Seguros Earnings Call Transcript: Q3 2025
Revenue grew 4.3% quarter-on-quarter to BRL 372 million, with adjusted net income up 8.8% and strong cash generation. Churn hit a five-year Q3 low, and a record 340 new products were launched, while judicial claims and competitive SME pricing remain key risks.
Qualicorp Consultoria e Corretora de Seguros Earnings Call Transcript: Q2 2025
Churn and net portfolio loss reached multi-year lows, driven by operational improvements, new product launches, and a focus on core retail healthcare. Revenue dipped due to portfolio divestment, but cash generation and cost control remain strong.
Qualicorp Consultoria e Corretora de Seguros Earnings Call Transcript: Q1 2025
Deleveraging and cash generation remain priorities, with BRL 142 million in free cash flow and a 1.34x net debt/EBITDA ratio. Revenue declined due to a smaller customer base, but operational efficiency improved margins. Judicial contingencies remain high but are expected to decrease by year-end.
Qualicorp Consultoria e Corretora de Seguros Earnings Call Transcript: Q4 2024
2024 was a year of operational turnaround, with reduced costs, improved capital structure, and expanded product offerings. Despite lower revenue and EBITDA due to industry-wide lawsuits, the company achieved strong cash flow and reduced net debt, setting a foundation for sustainable growth in 2025.
Qualicorp Consultoria e Corretora de Seguros Earnings Call Transcript: Q3 2024
Stable EBITDA and cash flow despite a 23% drop in managed lives, with the lowest churn in four years and strong cost discipline. New regional products and HMOs are gaining traction, while operational improvements and commercial realignment support future growth.
Qualicorp Consultoria e Corretora de Seguros Earnings Call Transcript: Q2 2024
Q2 2024 saw a sharp drop in portfolio size but resilient revenue and improved EBITDA, driven by operational efficiency and cost discipline. The company is mitigating industry-wide cancellations, launching new products, and focusing on deleveraging before resuming higher dividends.